{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T14:18:26Z","timestamp":1785161906287,"version":"3.55.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006668","name":"FONCyT","doi-asserted-by":"crossref","award":["PID 2012-0017"],"award-info":[{"award-number":["PID 2012-0017"]}],"id":[{"id":"10.13039\/501100006668","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004462","name":"National Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004462","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"CONICET","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.vaccine.2017.03.026","type":"journal-article","created":{"date-parts":[[2017,3,24]],"date-time":"2017-03-24T01:18:21Z","timestamp":1490318301000},"page":"2303-2307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Antigenic and immunogenic spectrum of foot-and-mouth disease vaccine strain O 1 Campos against representative viruses of topotypes that circulated in Asia over the past decade"],"prefix":"10.1016","volume":"35","author":[{"given":"S.","family":"Galdo Novo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Malirat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.D.","family":"Maradei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Espinoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Smitsaart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.R.","family":"Pedemonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Mattion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.E.","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Pt3","key":"10.1016\/j.vaccine.2017.03.026_b0005","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1099\/0022-1317-82-3-609","article-title":"Foot-and-mouth disease type O viruses exhibit genetically and geographically distinct evolutionary lineages (topotypes)","volume":"82","author":"Samuel","year":"2001","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2017.03.026_b0010","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0168-1702(02)00261-7","article-title":"FMD vaccines. Review","volume":"91","author":"Doel","year":"2003","journal-title":"Virus Res."},{"issue":"5","key":"10.1016\/j.vaccine.2017.03.026_b0015","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.vaccine.2014.11.058","article-title":"Antigenic and genetic comparison of foot-and-mouth disease virus serotype O Indian vaccine strain, O\/IND\/R2\/75 against currently circulating viruses","volume":"33","author":"Mahapatra","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.026_b0020","first-page":"11","article-title":"Updating of foot and mouth disease virus strains of epidemiological importance in South America","volume":"53","author":"Alonso","year":"1987","journal-title":"Bol Centr Panam Fiebre Aftosa"},{"issue":"6","key":"10.1016\/j.vaccine.2017.03.026_b0025","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1586\/14760584.4.6.903","article-title":"Evolving perception on the benefits of vaccination as foot-and-mouth disease control policy: contributions of South America","volume":"4","author":"Bergmann","year":"2005","journal-title":"Expert Rev Vaccines"},{"issue":"12","key":"10.1016\/j.vaccine.2017.03.026_b0030","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.3201\/eid1112.050908","article-title":"Pandemic strain of foot-and-mouth disease virus serotype O","volume":"11","author":"Knowles","year":"2005","journal-title":"Emerg Infect Dis"},{"issue":"May","key":"10.1016\/j.vaccine.2017.03.026_b0035","article-title":"Review of the global distribution of foot-and-mouth disease virus from 2007 to 2014","author":"Brito","year":"2015","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2017.03.026_b0040","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.vetmic.2008.07.011","article-title":"Rapid methodology for antigenic profiling of FMDV field strains and for the control of identity, purity and viral integrity in commercial virus vaccines using monoclonal antibodies","volume":"133","author":"Seki","year":"2009","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2017.03.026_b0045","unstructured":"OIE World Organisation for Animal Health. Foot and mouth disease. In: OIE Standards Commission, editor. Manual of diagnostic tests and vaccines for terrestrial animals, 6th ed. Paris (France): Office International des Epizooties; 2012 [chapter 2.1.8]."},{"key":"10.1016\/j.vaccine.2017.03.026_b0050","series-title":"Report on the \u201cSubproyecto para la correlaci\u00f3n de las t\u00e9cnicas de control de potencia de las vacunas contra la Fiebre Aftosa en los pa\u00edses de la Cuenca del R\u00edo de la Plata\u201d","author":"PANAFTOSA. Pan-American Foot-and-Mouth Disease Center","year":"1994"},{"key":"10.1016\/j.vaccine.2017.03.026_b0055","unstructured":"SENASA, 2006. Actual\u00edzase la reglamentaci\u00f3n que permite el control de las vacunas destinadas a la prevenci\u00f3n de la Fiebre Aftosa. Bolet\u00edn Oficial N\u00b0 30.940, Argentina: Servicio Nacional de Sanidad y Calidad Agroalimentaria (SENASA."},{"key":"10.1016\/j.vaccine.2017.03.026_b0060","doi-asserted-by":"crossref","first-page":"6577","DOI":"10.1016\/j.vaccine.2008.09.033","article-title":"Updating of the correlation between IpELISA titers and protection from virus challenge for the assessment of the potency of polyvalent aphthovirus vaccines in Argentina","volume":"26","author":"Maradei","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.026_b0065","doi-asserted-by":"crossref","first-page":"8230","DOI":"10.1016\/j.vaccine.2011.08.120","article-title":"Characterization of foot-and-mouth disease virus from outbreaks in Ecuador during 2009\u20132010 and cross-protection studies with the vaccine strain in use in the region","volume":"29","author":"Maradei","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.026_b0070","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.vetmic.2012.10.035","article-title":"Characterization of a type O foot-and-mouth disease virus re-emerging in the year 2011 in free areas of the Southern cone of South America and cross protection studies with the vaccine strain in use in the region","volume":"162","author":"Maradei","year":"2013","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2017.03.026_b0075","first-page":"2446","volume":"32","author":"Maradei","year":"2014","journal-title":"Emergence of antigenic variants of foot-and-mouth disease virus serotype O in Ecuador and preliminary evaluation of a field strain as a vaccine candidate vaccine"},{"key":"10.1016\/j.vaccine.2017.03.026_b0080","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.vaccine.2008.01.038","article-title":"High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus","volume":"26","author":"Brehm","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.026_b0085","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1016\/j.vaccine.2008.04.034","article-title":"Foot-and-mouth disease vaccine potency testing in cattle using homologous and heterologous challenge strains: Precision of the \u201cProtection against Podal Generalisation\u201d test","volume":"26","author":"Goris","year":"2008","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2017.03.026_b0090","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/0264-410X(93)90171-S","article-title":"Potency control of foot-and-mouth disease vaccine in cattle. Comparison of the 50% protective dose and the protection against generalization","volume":"11","author":"Vianna Filho","year":"1993","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2017.03.026_b0095","doi-asserted-by":"crossref","first-page":"186","DOI":"10.20506\/rst.18.1.1154","article-title":"Managing an animal health emergency in Taipei China: foot and mouth disease","volume":"18","author":"Chen","year":"1999","journal-title":"Rev Sci Tech Off Int Epiz"},{"key":"10.1016\/j.vaccine.2017.03.026_b0100","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/vr.145.25.731","article-title":"Sung HT Epidemiological characteristics and financial costs of the 1997 foot-and-mouth disease epidemic in Taiwan","volume":"145","author":"Yang","year":"1999","journal-title":"Vet Rec"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17303328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17303328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T08:20:44Z","timestamp":1535962844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17303328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":20,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0264410X17303328"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.026","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antigenic and immunogenic spectrum of foot-and-mouth disease vaccine strain O1 Campos against representative viruses of topotypes that circulated in Asia over the past decade","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}